Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review Article
  • Published:

Long-term outcomes of deep brain stimulation in Parkinson disease

Nature Reviews Neurology volume 15, pages 234–242 (2019)Cite this article

Subjects

Abstract

The efficacy of deep brain stimulation (DBS) for Parkinson disease (PD) is well established for up to 1 or 2 years, but long-term outcome data are still limited. In this Review, we critically discuss the evidence on the long-term outcomes of DBS and consider the clinical implications. Although many patients are lost to follow-up, the evidence indicates that subthalamic nucleus DBS improves motor function for up to 10 years, although the magnitude of improvement tends to decline over time. Functional scores recorded during on-medication periods worsen more quickly than those recorded in off periods, consistent with the degeneration of non-dopaminergic pathways. Dyskinesia, motor fluctuations and activities of daily living in off periods remain improved at 5 years, but quality-of-life scores have usually fallen below preoperative levels. The incidence and severity of dementia among patients receiving DBS are comparable to those among patients who receive medical treatment. Severe adverse events are rare, but adverse events such as dysarthria are common and probably under-reported. Long-term data on the outcomes of globus pallidus interna DBS are limited and mostly confirm the efficacy for dyskinesia. A trend towards offering DBS in the earlier stages of PD creates a need to identify factors that predict long-term outcomes and to discuss realistic expectations with patients preoperatively.

Key points

  • Subthalamic nucleus (STN) deep brain stimulation (DBS) can provide long-term improvements in motor function for patients with Parkinson disease (PD).

  • STN DBS does not prevent the neurodegenerative processes of PD; therefore, quality-of-life scores have usually fallen to preoperative levels by the 5-year time point.

  • Deterioration in quality of life often reflects the emergence of 3,4-dihydroxyphenylalanine (l-DOPA)-refractory or stimulation-resistant motor and non-motor features of PD, particularly impairments of gait, balance and speech.

  • Distinguishing stimulation-induced adverse effects from disease progression requires experience, a systematic approach to adjusting stimulation parameters and awareness of possible relationships with changes in dopaminergic medication.

  • Important factors in long-term outcomes of DBS are patient selection, precision of electrode targeting and experienced stimulation and medication adjustments.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Summary of long-term deep brain stimulation outcome studies.

Similar content being viewed by others

References

  1. Pollak, P. et al. Effects of the stimulation of the subthalamic nucleus in Parkinson disease [French]. Rev. Neurol. (Paris) 149, 175–176 (1993).

    CAS  Google Scholar 

  2. Benabid, A. L., Pollak, P., Louveau, A., Henry, S. & de Rougemont, J. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl. Neurophysiol. 50, 344–346 (1987).

    CAS  PubMed  Google Scholar 

  3. Benabid, A. L. et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 337, 403–406 (1991).

    Article  CAS  Google Scholar 

  4. Albe-Fessard, D. et al. Characteristic electric activities of some cerebral structures in man [French]. Ann. Chir. 17, 1185–1214 (1963).

    CAS  PubMed  Google Scholar 

  5. Limousin, P. et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 345, 91 (1995). This paper reports on the first three patients to be implanted with bilateral STN DBS.

    Article  CAS  Google Scholar 

  6. Deuschl, G. et al. A randomized trial of deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med. 355, 896–908 (2006). This article presents the first multicentre randomized trial of STN DBS versus the best medical treatment.

    Article  CAS  Google Scholar 

  7. Weaver, F. M. et al. Bilateral deep brain stimulation versus best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301, 63–73 (2009).

    Article  CAS  Google Scholar 

  8. Williams, A. et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson’s disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol. 9, 581–591 (2010).

    Article  Google Scholar 

  9. Schuepbach, W. M. M. et al. Neurostimulation for Parkinson’s disease with early motor complications. N. Engl. J. Med. 368, 610–622 (2013).

    Article  CAS  Google Scholar 

  10. Follett, K. A. et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson’s disease. N. Engl. J. Med. 362, 2077–2091 (2010). This paper presents the first multicentre randomized trial of STN DBS versus GPi DBS.

    Article  CAS  Google Scholar 

  11. Weaver, F. M. et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 79, 55–65 (2012).

    Article  CAS  Google Scholar 

  12. Odekerken, V. J. J. et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson’s disease (NSTAPS study): a randomised controlled trial. Lancet. Neurol. 12, 37–44 (2013).

    Article  Google Scholar 

  13. Odekerken, V. J. J. et al. GPi versus STN deep brain stimulation for Parkinson disease: three-year follow-up. Neurology 86, 755–761 (2016).

    Article  CAS  Google Scholar 

  14. Krack, P. et al. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson’s disease. N. Engl. J. Med. 349, 1925–1934 (2003). This paper reports on the 5-year follow-up of the first cohort of patients to receive STN DBS.

    Article  CAS  Google Scholar 

  15. Schupbach, W. M. M. et al. Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up. J. Neurol. Neurosurg. Psychiatry 76, 1640–1644 (2005).

    Article  CAS  Google Scholar 

  16. Wider, C., Pollo, C., Bloch, J., Burkhard, P. R. & Vingerhoets, F. J. G. Long-term outcome of 50 consecutive Parkinson’s disease patients treated with subthalamic deep brain stimulation. Parkinsonism Relat. Disord. 14, 114–119 (2008).

    Article  CAS  Google Scholar 

  17. Gervais-Bernard, H. et al. Bilateral subthalamic nucleus stimulation in advanced Parkinson’s disease: five year follow-up. J. Neurol. 256, 225–233 (2009).

    Article  Google Scholar 

  18. Simonin, C. et al. Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson’s disease: a second honeymoon. J. Neurol. 256, 1736–1741 (2009).

    Article  Google Scholar 

  19. Kishore, A. et al. Long-term stability of effects of subthalamic stimulation in Parkinson’s disease: Indian experience. Mov. Disord. 25, 2438–2444 (2010).

    Article  Google Scholar 

  20. Fasano, A. et al. Motor and cognitive outcome in patients with Parkinson’s disease 8 years after subthalamic implants. Brain 133, 2664–2676 (2010).

    Article  Google Scholar 

  21. Castrioto, A. et al. Ten-year outcome of subthalamic stimulation in Parkinson disease: a blinded evaluation. Arch. Neurol. 68, 1550–1556 (2011).

    Article  Google Scholar 

  22. Zibetti, M. et al. Beyond nine years of continuous subthalamic nucleus deep brain stimulation in Parkinson’s disease. Mov. Disord. 26, 2327–2334 (2011).

    Article  Google Scholar 

  23. Aviles-Olmos, I. et al. Long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease using an MRI-guided and MRI-verified approach. J. Neurol. Neurosurg. Psychiatry 85, 1419–1425 (2014).

    Article  Google Scholar 

  24. Shalash, A. et al. The impact of age and disease duration on the long term outcome of neurostimulation of the subthalamic nucleus. Parkinsonism Relat. Disord. 20, 1–6 (2013).

    Google Scholar 

  25. Jiang, L. L. et al. Long-term efficacy of subthalamic nucleus deep brain stimulation in Parkinson’s disease: a 5-year follow-up study in China. Chin. Med. J. (Engl.). 128, 2433–2438 (2015).

    Article  Google Scholar 

  26. Li, J., Zhang, Y. & Li, Y. Long-term follow-up of bilateral subthalamic nucleus stimulation in Chinese Parkinson’s disease patients. Br. J. Neurosurg. 29, 329–333 (2015).

    Article  Google Scholar 

  27. Hartmann, C. J. et al. Long-term evaluation of impedance levels and clinical development in subthalamic deep brain stimulation for Parkinson’s disease. Parkinsonism Relat. Disord. 21, 1247–1250 (2015).

    Article  CAS  Google Scholar 

  28. Lezcano, E. et al. Long-term impact on quality of life of subthalamic nucleus stimulation in Parkinson’s disease. J. Neurol. 263, 895–905 (2016).

    Article  Google Scholar 

  29. Moro, E. et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson’s disease. Mov. Disord. 25, 578–586 (2010).

    Article  Google Scholar 

  30. Volkmann, J. et al. Long-term effects of pallidal or subthalamic deep brain stimulation on quality of life in Parkinson’s disease. Mov. Disord. 24, 1154–1161 (2009).

    Article  Google Scholar 

  31. Volkmann, J. et al. Long-term results of bilateral pallidal stimulation in Parkinson’s disease. Ann. Neurol. 55, 871–875 (2004).

    Article  Google Scholar 

  32. St George, R. J., Nutt, J. G., Burchiel, K. J. & Horak, F. B. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 75, 1292–1299 (2010).

    Article  Google Scholar 

  33. Tagliati, M., Martin, C. & Alterman, R. Lack of motor symptoms progression in Parkinson’s disease patients with long-term bilateral subthalamic deep brain stimulation. Int. J. Neurosci. 120, 717–723 (2010).

    Article  Google Scholar 

  34. Piboolnurak, P. et al. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson’s disease. Mov. Disord. 22, 990–997 (2007).

    Article  Google Scholar 

  35. Lilleeng, B., Brønnick, K., Toft, M., Dietrichs, E. & Larsen, J. P. Progression and survival in Parkinson’s disease with subthalamic nucleus stimulation. Acta Neurol. Scand. 130, 292–298 (2014).

    Article  CAS  Google Scholar 

  36. Merola, A. et al. Medical therapy and subthalamic deep brain stimulation in advanced Parkinson’s disease: a different long-term outcome? J. Neurol. Neurosurg. Psychiatry. 85, 552–559 (2014).

    Article  Google Scholar 

  37. Merola, A. et al. Advanced therapies in Parkinson’s disease: long-term retrospective study. Parkinsonism Relat. Disord. 29, 104–108 (2016).

    Article  Google Scholar 

  38. Siderowf, A. et al. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson’s disease. Mov. Disord. 21, 746–753 (2006).

    Article  Google Scholar 

  39. Lilleeng, B., Gjerstad, M., Baardsen, R., Dalen, I. & Larsen, J. P. The long-term development of non-motor problems after STN-DBS. Acta Neurol. Scand. 132, 251–258 (2015).

    Article  CAS  Google Scholar 

  40. Kim, H. J. et al. Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson’s disease. J. Neurol. 261, 1090–1096 (2014).

    Article  Google Scholar 

  41. Combs, H. L. et al. Cognition and depression following deep brain stimulation of the subthalamic nucleus and globus pallidus pars internus in Parkinson’s disease: a meta-analysis. Neuropsychol. Rev. 25, 439–454 (2015).

    Article  Google Scholar 

  42. Zangaglia, R. et al. Deep brain stimulation and cognition in Parkinson’s disease: an eight-year follow-up study. Mov. Disord. 27, 1192–1194 (2012).

    Article  Google Scholar 

  43. Lhommée, E. et al. Subthalamic stimulation in Parkinson’s disease: restoring the balance of motivated behaviours. Brain 135, 1463–1477 (2012).

    Article  Google Scholar 

  44. Abbes, M. et al. Subthalamic stimulation and neuropsychiatric symptoms in Parkinson’s disease: results from a long-term follow-up cohort study. J. Neurol. Neurosurg. Psychiatry 89, 836–843 (2018).

    Article  Google Scholar 

  45. Broen, M., Duits, A., Visser-Vandewalle, V., Temel, Y. & Winogrodzka, A. Impulse control and related disorders in Parkinson’s disease patients treated with bilateral subthalamic nucleus stimulation: a review. Parkinsonism Relat. Disord. 17, 413–417 (2011).

    Article  Google Scholar 

  46. Jung, Y. J. et al. An 8-year follow-up on the effect of subthalamic nucleus deep brain stimulation on pain in Parkinson disease. JAMA Neurol. 72, 504–510 (2015).

    Article  Google Scholar 

  47. Fenoy, A. J. & Simpson, R. K. Jr Risks of common complications in deep brain stimulation surgery: management and avoidance. J. Neurosurg. 120, 132–139 (2014).

    Article  Google Scholar 

  48. Buhmann, C. et al. Adverse events in deep brain stimulation: a retrospective long-term analysis of neurological, psychiatric and other occurrences. PLOS ONE 12, e0178984 (2017).

    Article  Google Scholar 

  49. Weaver, F. M. et al. Survival in patients with Parkinson’s disease after deep brain stimulation or medical management. Mov. Disord. 32, 1756–1763 (2017). This article presents a study of survival in a large cohort of patients with DBS or medical management.

    Article  Google Scholar 

  50. Ngoga, D. et al. Deep brain stimulation improves survival in severe Parkinson’s disease. J. Neurol. Neurosurg. Psychiatry 85, 17–22 (2014).

    Article  Google Scholar 

  51. Foubert-Samier, A. et al. A long-term follow-up of weight changes in subthalamic nucleus stimulated Parkinson’s disease patients [French]. Rev. Neurol. (Paris) 168, 173–176 (2012).

    Article  CAS  Google Scholar 

  52. Reuter, S., Deuschl, G., Falk, D., Mehdorn, M. & Witt, K. Uncoupling of dopaminergic and subthalamic stimulation: life-threatening DBS withdrawal syndrome. Mov. Disord. 30, 1407–1413 (2015).

    Article  CAS  Google Scholar 

  53. Fukaya, C. et al. Predictive factors for long-term outcome of subthalamic nucleus deep brain stimulation for Parkinson’s disease. Neurol. Med. Chir. (Tokyo) 57, 166–171 (2017).

    Article  Google Scholar 

  54. Boel, J. A. et al. Cognitive and psychiatric outcome 3 years after globus pallidus pars interna or subthalamic nucleus deep brain stimulation for Parkinson’s disease. Parkinsonism Relat. Disord. 33, 90–95 (2016).

    Article  Google Scholar 

  55. Antonini, A. et al. A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J. Neurol. 258, 579–585 (2011).

    Article  CAS  Google Scholar 

  56. Moreau, C. et al. STN-DBS frequency effects on freezing of gait in advanced Parkinson disease. Neurology 71, 80–84 (2008).

    Article  CAS  Google Scholar 

  57. Blume, J. et al. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson’s disease. Clin. Neurol. Neurosurg. 159, 87–92 (2017).

    Article  CAS  Google Scholar 

  58. US National Library of Medicine. ClinicalTrials.gov http://www.clinicaltrials.gov/ct2/show/NCT03234478 (2018).

  59. Pagano, G., Ferrara, N., Brooks, D. J. & Pavese, N. Age at onset and Parkinson disease phenotype. Neurology 86, 1400–1407 (2016).

    Article  CAS  Google Scholar 

  60. Angeli, A. et al. Genotype and phenotype in Parkinson’s disease: lessons in heterogeneity from deep brain stimulation. Mov. Disord. 28, 1370–1375 (2013).

    Article  Google Scholar 

  61. Lythe, V. et al. GBA-associated Parkinson’s disease: progression in a deep brain stimulation cohort. J. Parkinsons Dis. 7, 635–644 (2017).

    Article  CAS  Google Scholar 

  62. Stefani, A. et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson’s disease. Brain 130, 1596–1607 (2007).

    Article  Google Scholar 

  63. Freund, H. J. et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch. Neurol. 66, 781–785 (2009).

    Article  Google Scholar 

  64. Gratwicke, J. et al. The nucleus basalis of Meynert: a new target for deep brain stimulation in dementia? Neurosci. Biobehav. Rev. 37, 2676–2688 (2013).

    Article  Google Scholar 

  65. Gratwicke, J. et al. Bilateral deep brain stimulation of the nucleus basalis of meynert for Parkinson disease dementia: a randomized clinical trial. JAMA Neurol. 75, 169–178 (2018).

    Article  Google Scholar 

  66. Lozano, A. M. et al. A phase II study of fornix deep brain stimulation in mild Alzheimer’s disease. J. Alzheimers Dis. 54, 777–787 (2016).

    Article  CAS  Google Scholar 

  67. Kuhn, J. et al. Deep brain stimulation of the nucleus basalis of Meynert in Alzheimer’s dementia. Mol. Psychiatry 20, 353–360 (2015).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

Review criteria

A PubMed search was performed using the terms “Deep Brain Stimulation”, “Subthalamic nucleus” and/or “STN”, “Globus Pallidus Interna” and/or “GPi” “Parkinson disease” and “Long-term”. From the 284 articles obtained from this search, we identified studies that included clinical scores at 5 years of follow-up or longer. Further studies were identified from article bibliographies. To avoid duplication caused by several articles published by the same DBS unit, only articles providing the most recent relevant data were referenced. Multicentre studies that overlapped with published data from single centres were not included. From each eligible study, directly comparable data were extracted to enable calculation of mean changes in motor and non-motor outcome measures from baseline to 1 year, 5 year and longer (8–11 year) follow-up periods.

Reviewer information

Nature Reviews Neurology thanks J. Volkmann and other anonymous reviewer(s) for their contribution to the peer review of this work.

Author information

Authors and Affiliations

  1. Department of Clinical and Movement Neurosciences, University College London, Queen Square Institute of Neurology, London, UK

    Patricia Limousin & Tom Foltynie

  2. National Hospital for Neurology and Neurosurgery, Queen Square, London, UK

    Patricia Limousin & Tom Foltynie

Authors
  1. Patricia Limousin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tom Foltynie
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The authors contributed equally to all aspects of the article.

Corresponding author

Correspondence to Patricia Limousin.

Ethics declarations

Competing interests

P.L. and T.F. have received honoraria and travel expenses for lectures from Boston Scientific and Medtronic. T.F. has also received honoraria from BIAL, Britannia and Profile Pharma.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Limousin, P., Foltynie, T. Long-term outcomes of deep brain stimulation in Parkinson disease. Nat Rev Neurol 15, 234–242 (2019). https://doi.org/10.1038/s41582-019-0145-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-019-0145-9

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing